Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.15
+0.02 (0.39%)
At close: Mar 6, 2026, 4:00 PM EST
5.16
+0.01 (0.19%)
After-hours: Mar 6, 2026, 5:12 PM EST
Myriad Genetics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Myriad Genetics stock have an average target of 8.06, with a low estimate of 6.00 and a high estimate of 11. The average target predicts an increase of 56.50% from the current stock price of 5.15.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Myriad Genetics stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 9 | 9 | 9 | 9 | 5 |
| Sell | 3 | 3 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 14 | 14 | 14 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +16.50% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6.5 → $6 | Hold | Maintains | $6.5 → $6 | +16.50% | Feb 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $8.5 | Buy | Maintains | $9 → $8.5 | +65.05% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $6.5 | Hold | Maintains | $6 → $6.5 | +26.21% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +74.76% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
883.76M
from 824.50M
Increased by 7.19%
Revenue Next Year
933.56M
from 883.76M
Increased by 5.64%
EPS This Year
0.06
from -3.95
EPS Next Year
0.19
from 0.06
Increased by 211.34%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 914.1M | 990.3M | |||
| Avg | 883.8M | 933.6M | |||
| Low | 842.8M | 876.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.9% | 12.1% | |||
| Avg | 7.2% | 5.6% | |||
| Low | 2.2% | -0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.23 | 0.43 | |||
| Avg | 0.06 | 0.19 | |||
| Low | -0.06 | 0.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 608.7% | |||
| Avg | - | 211.3% | |||
| Low | - | -51.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.